Journey Medical director receives 50,000 RSU grant

Smith Justin Adam reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Smith Justin Adam reported acquisition or exercise transactions in this Form 4 filing.

Journey Medical Corp director Justin Adam Smith received a grant of 50,000 restricted stock units as equity compensation. The award was granted on July 1, 2026 under Journey Medical Corp's 2015 Stock Plan, as amended. These restricted stock units vest over a long-term schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031, tying the director’s compensation to the company’s future performance. Following this grant, Smith directly holds a total of 231,618 shares and restricted stock units, which vest over various time periods.

Insider Trade Summary

Grant/Award: 50,000 shares

Grant/Award 1 txn

Insider Smith Justin Adam

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.0001 par value	50,000	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.0001 par value — 231,618 shares (Direct)

Footnotes (2)

1. F1. On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031.
2. F2. Includes restricted stock units, which vest over various time periods.

Key Figures

RSUs granted: 50,000 restricted stock units Vesting tranche 1: 16,666 shares Vesting tranche 2: 16,667 shares +3 more

6 metrics

RSUs granted 50,000 restricted stock units Grant date July 1, 2026 under 2015 Stock Plan

Vesting tranche 1 16,666 shares RSUs vesting on July 1, 2029

Vesting tranche 2 16,667 shares RSUs vesting on July 1, 2030

Vesting tranche 3 16,667 shares RSUs vesting on July 1, 2031

Holdings after grant 231,618 shares and RSUs Direct holdings following July 1, 2026 transaction

Price per share $0.0000 per unit Indicates compensation grant, not market purchase

Key Terms

restricted stock units, 2015 Stock Plan, vest, grant, award, or other acquisition, +1 more

5 terms

restricted stock units financial

"the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2015 Stock Plan financial

"pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule"

vest financial

"which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

direct ownership financial

"direct_or_indirect: D and ownership_type: direct"

FAQ

What did Journey Medical Corp (DERM) director Justin Adam Smith report in this Form 4?

Director Justin Adam Smith reported receiving 50,000 restricted stock units as an equity award. The grant was made on July 1, 2026 under Journey Medical Corp’s 2015 Stock Plan, aligning his compensation with the company’s long-term performance and share value.

How many Journey Medical Corp (DERM) restricted stock units were granted to Justin Adam Smith?

Justin Adam Smith was granted 50,000 restricted stock units. This equity award represents a future right to receive shares of Journey Medical Corp common stock, subject to the vesting schedule outlined in the company’s 2015 Stock Plan, as amended, and continued service conditions.

What is the vesting schedule for Justin Adam Smith’s 50,000 Journey Medical Corp (DERM) RSUs?

The 50,000 restricted stock units vest in three tranches over several years. 16,666 units vest on July 1, 2029, 16,667 on July 1, 2030, and 16,667 on July 1, 2031, providing long-term incentive alignment with Journey Medical Corp’s performance.

How many Journey Medical Corp (DERM) shares and RSUs does Justin Adam Smith hold after this grant?

After the July 1, 2026 grant, Justin Adam Smith directly holds 231,618 shares and restricted stock units. This total includes RSUs that vest over various time periods, reflecting both current ownership and future equity that may settle into shares.

Was Justin Adam Smith’s Journey Medical Corp (DERM) RSU grant an open-market purchase or a compensation award?

The transaction was a compensation award, not an open-market purchase. It is coded as a grant or award acquisition, with a price per share of $0.0000, indicating equity granted under Journey Medical Corp’s stock plan rather than shares bought in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Justin Adam

(Last) (First) (Middle)

C/O JOURNEY MEDICAL CORPORATION

9237 E VIA DE VENTURA BLVD., SUITE 105

(Street)

SCOTTSDALE ARIZONA 85258

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Journey Medical Corp [ DERM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	07/01/2026		A		50,000(1)	A	$0	231,618(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031.

2. Includes restricted stock units, which vest over various time periods.

	/s/ Ramsey Alloush, attorney-in-fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)